Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,746 | 32,786 | 24,459 | 18,890 | 30,373 |
| Marketable Securities | 20,575 | 24,147 | 33,747 | 106,077 | 26,954 |
| Receivables | 41,615 | 30,550 | 40,320 | 15,472 | 15,973 |
| Inventories | 6,002 | 5,522 | 9,118 | 6,616 | 1,638 |
| TOTAL | $135,103 | $99,266 | $115,903 | $154,467 | $88,983 |
| Non-Current Assets | |||||
| PPE Net | 92 | 165 | 857 | 2,184 | 2,676 |
| Intangibles | 27,100 | 13,878 | 14,949 | 0 | 0 |
| Other Non-Current Assets | 1,681 | 3,916 | 2,570 | 10,677 | 18,719 |
| TOTAL | $28,873 | $17,959 | $18,376 | $12,861 | $21,395 |
| Total Assets | $163,976 | $117,225 | $134,279 | $167,328 | $110,378 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,339 | 7,142 | 22,508 | 3,795 | 3,707 |
| Accrued Expenses | 14,212 | 12,189 | 16,574 | 21,074 | 14,481 |
| Other current liabilities | 26,440 | 19,326 | 17,142 | 21,421 | 0 |
| TOTAL | $63,299 | $53,267 | $65,211 | $63,554 | $40,841 |
| Non-Current Liabilities | |||||
| Long Term Debt | 52,408 | 52,373 | 39,448 | 19,914 | 19,815 |
| Deferred Revenues | 1,355 | 1,355 | 1,369 | 2,596 | 3,018 |
| Other Non-Current Liabilities | 44,981 | 40,229 | 43,236 | 53,486 | 15,696 |
| TOTAL | $97,389 | $92,602 | $82,684 | $73,400 | $35,511 |
| Total Liabilities | $160,688 | $145,869 | $147,895 | $136,954 | $76,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,863 | 17,538 | 17,365 | 17,168 | 17,004 |
| Common Shares | 18 | 17 | 174 | 172 | 169 |
| Retained earnings | -1,390,065 | -1,407,550 | -1,382,459 | -1,323,886 | -1,305,972 |
| Other shareholders' equity | 10 | 8 | -153 | -102 | -4 |
| TOTAL | $3,288 | $-28,644 | $-13,616 | $30,374 | $34,026 |
| Total Liabilities And Equity | $163,976 | $117,225 | $134,279 | $167,328 | $110,378 |